India rejects J&J’s attempt to extend patent on TB drug Subject : Science and tech Section: Health Concept : The Indian Patent Office rejected S. pharmaceutical giant Johnson & Johnson’s (J&J) attempt to extend its monopoly on the manufacturing of the anti-tuberculosis drug Bedaquiline in India beyond July 2023. This will pave the […]